Efficient synthesis of optically active α-substituted glutamate analogs possessing α-hydroxymethyl and α-alkoxymethyl groups

Highly enantioselective synthesis of (2R)-α-(hydroxymethyl)glutamate (1), a selective agonist of mGluR2 and 3, was achieved in short steps using an asymmetric version of the Strecker synthesis. This was converted into its α-methoxymethyl- and α-benzyloxymethyl derivatives 2 and 3, possible ligands as tools to investigate glutamate receptors, via protection of the sterically hindered amino group by means of phase transfer catalyst.     

A new approach to the synthesis of racemic analogs of 1,5-dimethyl-branched insect pheromones from 4-methyltetrahydropyran

A new procedure was developed for the synthesis of racemic analogs of 1,5-dimethyl-branched insect pheromones based on monoalkylation of ethyl acetoacetate with 1-acetoxy-5-bromo-3-methylpentane produced upon decyclization of 4-methyltetrahydropyran.     

New conversion of Friendl(a)nder reaction of 3-amino-lH-benzo[f]chromene-2-carbonitriles with cyclohexanone

Two different skeletons of heterocyclic compounds, quinoline and quinazolinone analogs could be obtained by a novel one-potsynthesis from substituted 3-amino-lH-benzo[f]chromene-2-carbonitrile derivatives and cyclohexanone in DMF in the catalyst ofanhydrous zinc chloride under reflux. A plausible mechanism was proposed.     

Molecular structures of some D-homo-6-oxa-8α analogs of steroidal estrogens

By X-ray crystallographic analysis and NMR spectroscopy it was demonstrated that the conformations of several D-homo-6-oxa-8α analogs of steroidal estrogens are similar in the crystal and in solution. The distances between the hydrogen atoms in these molecules, calculated by the ab initio and MM⁺ methods, correspond to the experimental data. __________ Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 2, pp. 202–207, February, 2008.     

Aspirin attenuates the anti-inflammatory effects of theophylline via inhibition of cAMP production in mice with non-eosinophilic asthma

Theophylline is commonly used to treat severe asthma and chronic obstructive pulmonary disease (COPD) characterized by non-eosinophilic inflammation. Acetyl salicylic acid (ASA) is one of the most widely used medications worldwide, but up to 20% of patients with asthma experience aggravated respiratory symptoms after taking ASA. Here we evaluated the adverse effect of ASA on the therapeutic effect of theophylline in mice with non-eosinophilic asthma. A non-eosinophilic asthma mouse model was induced by airway sensitization with lipopolysaccharide-containing allergen and then challenged with allergen alone. Therapeutic intervention was performed during allergen challenge. Theophylline inhibited lung inflammation partly induced by T_h1 immune response. ASA attenuated the beneficial effects of theophylline. However, co-administration of the ASA metabolite salicylic acid (SA) showed no attenuating effect on theophylline treatment. The therapeutic effect of theophylline was associated with increase in cAMP levels, which was blocked by co-treatment of theophylline and ASA. ASA co-treatment also attenuated the anti-inflammatory effects of a specific phosphodiesterase 4 inhibitor. These results demonstrate that ASA reverses anti-inflammatory effects of theophylline, and that ASA exerts its adverse effects through the inhibition of cAMP production. Our data suggest that ASA reverses lung inflammation in patients taking theophylline, although clinical evidence will be needed.     

猪瘟病毒HCLV株E_2核苷酸序列与结构分析

用 Ｒ Ｔ Ｐ Ｃ Ｒ技术从 Ｃ Ｓ Ｆ Ｖ Ｈ Ｃ Ｌ Ｖ 株 Ｆ４８２ 代感染兔脾的细胞总 Ｒ Ｎ Ａ 中分段扩增出了 Ｃ Ｓ Ｆ Ｖ Ｅ２ 基因特异的３ 个部分重叠的 Ｄ Ｎ Ａ 片段（大小分别为 ４９９ ｂｐ、５７２ ｂｐ 和 ２４５ ｂｐ）,并将之分别克隆到ｐ Ｇ Ｅ Ｍ Ｔ 载体上 经核苷酸序列测定和片段重叠完成了包含 Ｅ２ 全长基因的 １ １４４ ｂｐ 序列的测定,其 Ｇ Ｃ含量为４９．０％ ：核苷酸序列与国外报道的各株病毒的 Ｅ２ 基因同源性分别为８３．５％ ～９７．５％ ;其推导的氨基酸序列的同源性也分别为８９．３％～９６．２％ ,变异主要分布在 Ｅ２ 蛋白的 Ｎ 半部分     

Designing and Synthesis of Novel Amidated Fentanyl Analogs

Some new amidated fentanyl (=N‐[1‐(2‐phenylethyl)piperidin‐4‐yl]‐N‐phenylpropanamide) analogs with a 4‐(N‐phenylamido)piperidine scaffold and additional amide bonds have been designed and synthesized through Ugi four‐component reaction (Ugi‐4CR). Good‐to‐high yields, diversity‐oriented synthesis, and possible applications in drug discovery are advantages of this approach.     

氯吡格雷抵抗机制的研究进展及临床处理策略

冠心病患者尽管接受了标准的氯吡格雷治疗，但仍有一部分患者对氯吡咯雷表现为低反应甚至无反应，称为氯吡格雷抵抗。导致这种抵抗现象的可能原因包括患者个体的基因多态性和药物之间的相互作用等。临床处理的主要对策有提高氯吡格雷的给药剂量和采用新型药物等。笔者就现有的临床研究证据对氯吡格雷抵抗的定义、发生机制及临床干预策略进行了综述。